Results 161 to 170 of about 32,355 (207)

Effects of Unilateral High Frequency Stimulation of the Subthalamic Nucleus on Risk-avoidant Behavior in a Partial 6-hydroxydopamine Model of Parkinson's Disease. [PDF]

J Integr Neurosci
Hillan SG, Asp AJ, Pramanik LB, Mukerjee AA, Mulder CB, Lujan WD, Silvernail JL, Chang SY, Boschen SL, Lujan JL.   +9 more
europepmc   +1 more source

Role of Nitric Oxide Modulators in Neuroprotective Effects of Mangiferin in 6-Hydroxydopamine-induced Parkinson's Disease in Rats. [PDF]

Ann Neurosci
Tiwari PC, Chaudhary MJ, Pal R, Nath R.
europepmc   +1 more source

Serotonergic system in hypoxic ventilatory response in unilateral rat model of Parkinson’s disease [PDF]

, 2017

core   +1 more source

Potentiation of leptazol seizures by 6-hydroxydopamine

Journal of Pharmacy and Pharmacology, 1973
M E, Corcoran, H C, Fibiger, E G, McGeer, J A, Wada   +3 more
openaire   +2 more sources

Sustained Systemic Antioxidative Effects of Intermittent Theta Burst Stimulation beyond Neurodegeneration: Implications in Therapy in 6-Hydroxydopamine Model of Parkinson's Disease. [PDF]

Antioxidants (Basel)
Zeljkovic Jovanovic M, Stanojevic J, Stevanovic I, Ninkovic M, Nedeljkovic N, Dragic M.   +5 more
europepmc   +1 more source

The effect of inhibiting hindbrain A2 noradrenergic neurons by 6-Hydroxydopamine on lipopolysaccharide-treated male rats autistic animal model. [PDF]

Saudi Pharm J
Alhamami HN, Albogami AM, Algahtani MM, Alqinyah M, Alanazi WA, Alasmari F, Alhazzani K, Alanazi AZ, Alassmrry YA, Alhamed AS.   +9 more
europepmc   +1 more source

Increase in adrenal dopamine following 6-hydroxydopamine

Journal of Pharmacy and Pharmacology, 1974
openaire   +2 more sources

Dopamine-dependent compensation maintains motor behavior in mice with developmental ablation of dopaminergic neurons [PDF]

, 2013
DeMaro, Joseph A, III, Gereau, Robert W, IV, Golden, Judith P, Hoshi, Masato, Jain, Sanjay, Johnson, Eugene M, Jr, Knoten, Amanda, Pehek, Elizabeth   +7 more
core   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Behavioral pharmacology of 6-hydroxydopamine

Life Sciences, 1973
Publisher Summary This chapter reviews the behavioral pharmacology of 6-hydroxydopamine. The ability of 6-hydroxydopamine (6-HDA) to produce a specific degeneration of central catecholamine-containing neurons offers a unique opportunity to study the consequences of loss of these neurons on the performance of a conditioned response. The 6-HDA treatment
R.I. Schoenfeld, M.J. Zigmond
  +5 more sources